Idenix Pharmaceuticals, Inc.

NASDAQ: IDIX
Teva Pharmaceutical resume a deal-making strategy that made it one of the most acquisitive drug companies of the past decade. Could one of these biotech takeover candidates be the next target?
The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility that some of the top names may also become takeover targets this year.
Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%. Its trading volume of almost 9.2 million shares was almost eight-times the normal...
Stocks are showing the concern over the shenanigans taking place in Washington, and investors have to worry which stocks they should be buying, selling or avoiding. It turns out that analysts think...
U.S. equity markets opened higher this morning after yesterday’s bloodbath. There was no economic data of note released today in either Asia or the U.S. In Europe, the eurozone’s current account...
Investors and traders are often on the hunt for fresh research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street firms and...
Here are today’s five biggest gaining stocks at closing: Stereotaxis Inc. (NASDAQ: STXS) is up 30.2% at $2.33. Novogen Ltd. (NASDAQ: NVGN) is up 18.8% at $5.24. SemiLEDS Corp. (NASDAQ: LEDS) is up...
Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) was covered this morning in our analyst upgrades and downgrades daily summary, but call is worth a closer look. Deutsche Bank initiated the small biotech...
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday. Check Point Software Technologies Ltd. (NASDAQ: CHKP) started as Market Perform...
These are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Wednesday. Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) raised to Buy from Underperform...
Stocks are mixed Monday, with the Dow Jones Industrial Average down 0.23%, the Nasdaq up 0.15% and the S&P 500 down 0.05%. Today’s market winners include two buyouts and a company poised to...
These are some of today’s top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday. Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) Started as Outperform...
News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment has the entire drug sector up in arms as it pertains to...
US equities opened strongly this morning and managed to maintain solid gains throughout the day. The in-line earnings report last night from Alcoa Inc. (NYSE: AA) and higher commodity prices —...